Chang T K, Wang Y, Liu A M, Tung J C
Department of Pediatrics, Shalu Tung's General Hospital, No. 8, Cheng Kung West St., Shalu, Taichung 43304, Taiwan.
Acta Paediatr Taiwan. 2001 Jan-Feb;42(1):39-41.
Thanatophoric dysplasia is a sporadic, nearly always lethal congenital skeletal dysplasia. It is characterized by shortening of the limbs, a severely small thorax, macrocephaly, and platyspondyly. There are two major subtypes: a short, curved femur characterizes type I, and a straighter femur with cloverleaf skull characterizes type II. Recently, mutations in the fibroblast growth factor receptor 3 (FGFR-3) gene have been identified in both subtypes, which suggest that thanatophoric dysplasia is a genetically homogenous skeletal disorder. Most affected neonates die of respiratory failure, due to narrow thorax with pulmonary hypoplasia. Antenatal sonographic diagnosis is feasible in the second trimester of pregnancy, but differentiating thanatophoric dysplasia from non-lethal skeletal disorders is very important. At the present time, however, prenatal genetic screening seems unpractical.
致死性骨发育不全是一种散发性、几乎总是致命的先天性骨骼发育不良。其特征为四肢短小、胸廓严重狭小、巨头畸形和脊椎扁平。有两种主要亚型:I型以短而弯曲的股骨为特征,II型以较直的股骨和三叶形颅骨为特征。最近,在两种亚型中均已鉴定出成纤维细胞生长因子受体3(FGFR - 3)基因突变,这表明致死性骨发育不全是一种基因同质的骨骼疾病。大多数受影响的新生儿死于呼吸衰竭,原因是胸廓狭窄伴肺发育不全。产前超声诊断在妊娠中期是可行的,但将致死性骨发育不全与非致命性骨骼疾病区分开来非常重要。然而,目前产前基因筛查似乎不切实际。